KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Ingredients (ALTO) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Alto Ingredients (ALTO) over the last 15 years, with Q3 2025 value amounting to $217.5 million.

  • Alto Ingredients' Cost of Revenue fell 1153.61% to $217.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $904.0 million, marking a year-over-year decrease of 905.46%. This contributed to the annual value of $955.5 million for FY2024, which is 2085.26% down from last year.
  • According to the latest figures from Q3 2025, Alto Ingredients' Cost of Revenue is $217.5 million, which was down 1153.61% from $220.4 million recorded in Q2 2025.
  • In the past 5 years, Alto Ingredients' Cost of Revenue registered a high of $356.7 million during Q3 2022, and its lowest value of $204.9 million during Q1 2021.
  • In the last 5 years, Alto Ingredients' Cost of Revenue had a median value of $282.9 million in 2021 and averaged $280.6 million.
  • Within the past 5 years, the most significant YoY rise in Alto Ingredients' Cost of Revenue was 12127.64% (2021), while the steepest drop was 3681.75% (2021).
  • Alto Ingredients' Cost of Revenue (Quarter) stood at $343.4 million in 2021, then increased by 1.86% to $349.8 million in 2022, then decreased by 21.05% to $276.2 million in 2023, then dropped by 13.91% to $237.7 million in 2024, then dropped by 8.52% to $217.5 million in 2025.
  • Its Cost of Revenue stands at $217.5 million for Q3 2025, versus $220.4 million for Q2 2025 and $228.3 million for Q1 2025.